These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1934454)

  • 81. [Neuromuscular diseases with eosinophilia].
    Pellissier JF; Figarella-Branger D; Serratrice G
    Med Trop (Mars); 1998; 58(4 Suppl):471-6. PubMed ID: 10410368
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan.
    de Oliveira JS; Auerbach SB; Sullivan KM; Sale GE
    Bone Marrow Transplant; 1993 Feb; 11(2):163-7. PubMed ID: 8435665
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Eosinophilia-myalgia syndrome in association with L-tryptophan ingestion.
    Gresh JP; Vasey FB; Espinoza LR; Adelman HM; Germain BF
    J Rheumatol; 1990 Nov; 17(11):1557-8. PubMed ID: 2273503
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Movement disorders in the eosinophilia-myalgia syndrome: tremor, myoclonus, and myokymia.
    Kaufman LD; Kaufman MA; Krupp LB
    J Rheumatol; 1995 Jan; 22(1):157-60. PubMed ID: 7699663
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Restrictive cardiomyopathy associated with the eosinophilia-myalgia syndrome.
    Berger PB; Duffy J; Reeder GS; Karon BL; Edwards WD
    Mayo Clin Proc; 1994 Feb; 69(2):162-5. PubMed ID: 8309268
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The toxic oil syndrome and the eosinophilia-myalgia syndrome: pursuing clinical parallels.
    Hertzman PA; Borda IA
    J Rheumatol; 1993 Oct; 20(10):1707-10. PubMed ID: 8295182
    [No Abstract]   [Full Text] [Related]  

  • 87. Eosinophilia-myalgia syndrome: myopathic electrodiagnostic characteristics.
    Tanhehco JL; Wiechers DO; Golbus J; Neely SE
    Muscle Nerve; 1992 May; 15(5):561-7. PubMed ID: 1584247
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome.
    Kilbourne EM; Posada de la Paz M; Abaitua Borda I; Diez Ruiz-Navarro M; Philen RM; Falk H
    J Am Coll Cardiol; 1991 Sep; 18(3):711-7. PubMed ID: 1869734
    [TBL] [Abstract][Full Text] [Related]  

  • 89. An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use.
    Belongia EA; Hedberg CW; Gleich GJ; White KE; Mayeno AN; Loegering DA; Dunnette SL; Pirie PL; MacDonald KL; Osterholm MT
    N Engl J Med; 1990 Aug; 323(6):357-65. PubMed ID: 2370887
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome.
    Kilbourne EM; Philen RM; Kamb ML; Falk H
    J Rheumatol Suppl; 1996 Oct; 46():81-8; discussion 89-91. PubMed ID: 8895184
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Peak AAA fatty acid homolog contaminants present in the dietary supplement l-Tryptophan associated with the onset of eosinophilia-myalgia syndrome.
    Klarskov K; Gagnon H; Racine M; Boudreault PL; Normandin C; Marsault E; Gleich GJ; Naylor S
    Toxicol Lett; 2018 Sep; 294():193-204. PubMed ID: 29800716
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Tryptophan-induced eosinophilia-myalgia syndrome.
    Criswell LA; Sack KE
    West J Med; 1990 Sep; 153(3):269-74. PubMed ID: 2219890
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Pathologic manifestations of the eosinophilia myalgia syndrome: analysis of 11 cases.
    Lin JD; Phelps RG; Gordon ML; Hilfer JB; Wolfe DE; Venkataseshan VS; Fleischmajer R
    Hum Pathol; 1992 Apr; 23(4):429-37. PubMed ID: 1563745
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Eosinophilic fasciitis associated with L-tryptophan ingestion.
    Hamilton ME
    Ann Rheum Dis; 1991 Jan; 50(1):55-6. PubMed ID: 1994870
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Eosinophilia-myalgia syndrome and tryptophan production: a cautionary tale.
    Mayeno AN; Gleich GJ
    Trends Biotechnol; 1994 Sep; 12(9):346-52. PubMed ID: 7765187
    [TBL] [Abstract][Full Text] [Related]  

  • 96. L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat.
    Crofford LJ; Rader JI; Dalakas MC; Hill RH; Page SW; Needham LL; Brady LS; Heyes MP; Wilder RL; Gold PW
    J Clin Invest; 1990 Nov; 86(5):1757-63. PubMed ID: 2243145
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Eosinophilia-myalgia syndrome. A clinical case series of 21 patients. New Mexico Eosinophilia-Myalgia Syndrome Study Group.
    Philen RM; Eidson M; Kilbourne EM; Sewell CM; Voorhees R
    Arch Intern Med; 1991 Mar; 151(3):533-7. PubMed ID: 2001136
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Eosinophilia-myalgia syndrome following administration of a L-tryptophan preparation].
    Frick P; Frey R
    Schweiz Med Wochenschr; 1990 Nov; 120(44):1633-5. PubMed ID: 2251478
    [TBL] [Abstract][Full Text] [Related]  

  • 99. L-tryptophan and eosinophilia-myalgia syndrome in New Mexico.
    Eidson M; Philen RM; Sewell CM; Voorhees R; Kilbourne EM
    Lancet; 1990 Mar; 335(8690):645-8. PubMed ID: 1969024
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Eosinophilia-myalgia syndrome, eosinophilic fasciitis, and related fibrosing disorders.
    Varga J; Kähäri VM
    Curr Opin Rheumatol; 1997 Nov; 9(6):562-70. PubMed ID: 9375286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.